Proven or Suspected Gram-negative Bacterial Infection
1 clinical trials · Condition
◉ Watch Proven or Suspected Gram-negative Bacterial Infection
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010) (NCT02266706) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-09-17 |
Track Proven or Suspected Gram-negative Bacterial Infection automatically
Every clearance here is in the API, with alerts when new ones post.